Motif ID: Tgif1_Meis3
Z-value: 3.446


Transcription factors associated with Tgif1_Meis3:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Meis3 | ENSMUSG00000041420.12 | Meis3 |
Tgif1 | ENSMUSG00000047407.11 | Tgif1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tgif1 | mm10_v2_chr17_-_70851710_70851738 | -0.89 | 7.0e-15 | Click! |
Meis3 | mm10_v2_chr7_+_16175085_16175139 | 0.55 | 1.9e-04 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.2 | 52.8 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
9.3 | 37.3 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
6.0 | 18.0 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
5.7 | 17.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
4.2 | 8.4 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
3.5 | 14.1 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
3.5 | 10.5 | GO:1903011 | negative regulation of bone development(GO:1903011) |
3.5 | 10.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
3.4 | 3.4 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
3.3 | 6.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
3.1 | 12.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.9 | 14.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.7 | 11.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
2.6 | 7.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
2.5 | 10.1 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
2.5 | 19.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
2.4 | 7.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
2.4 | 2.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.3 | 6.9 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
2.1 | 6.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.1 | 6.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
2.1 | 2.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
2.1 | 14.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.1 | 10.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
2.0 | 6.1 | GO:0070428 | granuloma formation(GO:0002432) negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) toll-like receptor 5 signaling pathway(GO:0034146) regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
2.0 | 10.1 | GO:0051182 | coenzyme transport(GO:0051182) |
2.0 | 9.9 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
2.0 | 11.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.9 | 9.6 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.8 | 11.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.8 | 9.1 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
1.7 | 5.2 | GO:0070973 | COPI-coated vesicle budding(GO:0035964) protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.7 | 6.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.7 | 21.7 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
1.7 | 15.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.7 | 6.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.6 | 12.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.5 | 4.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.5 | 4.5 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
1.5 | 6.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
1.5 | 5.9 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
1.5 | 8.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.4 | 8.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.4 | 11.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.4 | 6.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.4 | 6.9 | GO:0090292 | nuclear migration along microfilament(GO:0031022) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.3 | 9.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.3 | 11.9 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
1.3 | 9.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.3 | 11.8 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.3 | 6.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.3 | 6.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.3 | 14.2 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
1.3 | 6.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.3 | 3.9 | GO:0060022 | hard palate development(GO:0060022) |
1.3 | 3.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) regulation of microglial cell activation(GO:1903978) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
1.3 | 3.8 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.3 | 3.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.2 | 3.7 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
1.2 | 4.9 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.2 | 4.9 | GO:1990743 | protein sialylation(GO:1990743) |
1.2 | 2.4 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
1.2 | 6.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.2 | 7.2 | GO:0019695 | choline metabolic process(GO:0019695) |
1.2 | 3.6 | GO:0002159 | desmosome assembly(GO:0002159) |
1.2 | 7.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.2 | 8.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.2 | 4.7 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.2 | 3.5 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
1.2 | 3.5 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
1.2 | 3.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.1 | 3.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
1.1 | 34.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.1 | 3.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
1.1 | 4.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.1 | 3.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.1 | 6.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 3.2 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
1.1 | 7.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.1 | 3.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.1 | 5.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
1.0 | 3.1 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
1.0 | 3.1 | GO:0043379 | memory T cell differentiation(GO:0043379) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.0 | 3.1 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
1.0 | 3.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.0 | 3.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 3.0 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
1.0 | 10.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.0 | 5.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.0 | 5.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
1.0 | 4.9 | GO:0070417 | cellular response to cold(GO:0070417) |
1.0 | 5.9 | GO:0010730 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.0 | 2.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.0 | 3.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.0 | 2.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.0 | 5.7 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
1.0 | 16.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.0 | 5.7 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
1.0 | 3.8 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
1.0 | 2.9 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.9 | 2.8 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.9 | 16.9 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.9 | 12.9 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.9 | 8.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 11.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.9 | 0.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.9 | 1.8 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.9 | 14.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.9 | 5.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.9 | 2.6 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.9 | 2.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.8 | 0.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.8 | 5.1 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.8 | 6.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.8 | 9.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.8 | 2.5 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.8 | 2.4 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.8 | 7.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.8 | 0.8 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
0.8 | 2.4 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.8 | 3.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.8 | 5.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.8 | 7.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.8 | 3.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.8 | 2.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.8 | 2.3 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.8 | 2.3 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.8 | 3.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.8 | 3.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.8 | 2.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.8 | 1.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.8 | 3.8 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.8 | 4.5 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.8 | 4.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.7 | 2.2 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.7 | 6.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.7 | 2.2 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.7 | 2.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.7 | 2.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.7 | 2.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.7 | 5.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.7 | 3.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.7 | 3.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.7 | 0.7 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
0.7 | 17.2 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.7 | 2.1 | GO:0015867 | ATP transport(GO:0015867) |
0.7 | 2.8 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
0.7 | 4.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.7 | 2.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.7 | 1.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.7 | 2.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.7 | 2.1 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.7 | 4.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.7 | 4.8 | GO:0015808 | L-alanine transport(GO:0015808) |
0.7 | 2.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 4.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.7 | 3.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.7 | 2.7 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.7 | 3.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.7 | 1.3 | GO:2000620 | regulation of histone H4-K16 acetylation(GO:2000618) positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.7 | 2.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.6 | 7.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.6 | 1.9 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.6 | 24.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 0.6 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.6 | 4.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.6 | 6.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.6 | 2.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 5.7 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.6 | 2.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 4.3 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.6 | 4.2 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.6 | 3.6 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 5.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.6 | 4.7 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.6 | 2.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.6 | 13.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.6 | 1.7 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
0.6 | 1.7 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.6 | 1.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.6 | 8.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 1.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.6 | 4.0 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.6 | 7.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.6 | 2.2 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.6 | 6.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 1.7 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.5 | 2.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 1.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 7.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.5 | 2.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 2.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 5.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 6.9 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.5 | 2.6 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.5 | 4.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.5 | 3.1 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.5 | 3.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 2.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 5.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 4.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.5 | 2.5 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.5 | 2.0 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.5 | 1.5 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.5 | 1.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.5 | 2.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.5 | 1.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.5 | 1.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.5 | 1.9 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.5 | 3.4 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.5 | 5.3 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.5 | 1.4 | GO:0008050 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.5 | 12.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 3.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.5 | 0.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.5 | 6.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 2.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 3.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 3.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 2.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.4 | 2.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.4 | 3.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.4 | 0.9 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 1.7 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 3.8 | GO:0098907 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.4 | 4.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 1.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 1.2 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.4 | 0.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 1.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 3.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.4 | 2.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 6.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 4.5 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 2.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 2.4 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.4 | 4.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.4 | 2.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 14.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.4 | 0.8 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.4 | 1.2 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.4 | 1.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 1.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.4 | 10.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 2.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.4 | 6.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.4 | 1.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.4 | 1.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 5.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.4 | 4.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.4 | 1.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 2.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 2.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 0.7 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 5.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 2.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 1.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 26.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 4.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 2.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.3 | 6.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.3 | 8.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 1.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.3 | 3.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 1.0 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 1.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.3 | 12.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 2.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 3.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 0.7 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 2.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.3 | 1.9 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 1.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 1.0 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.3 | 1.3 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.3 | 1.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 1.9 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.3 | 2.2 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 0.9 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.3 | 1.6 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.3 | 5.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.3 | 0.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.5 | GO:0021508 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.3 | 1.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 0.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.3 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.3 | 4.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 2.4 | GO:0031274 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 20.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.9 | GO:0019085 | early viral transcription(GO:0019085) |
0.3 | 10.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 5.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.3 | 6.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 1.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 2.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 0.9 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.3 | 1.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 3.1 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.3 | 0.8 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.3 | 3.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 1.7 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.3 | 3.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.3 | 5.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.3 | 3.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 0.3 | GO:0032811 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) |
0.3 | 2.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.3 | 1.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 2.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 1.3 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.3 | 1.6 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.3 | 1.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 1.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 1.5 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
0.3 | 2.8 | GO:0030539 | male genitalia development(GO:0030539) |
0.3 | 3.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 3.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 2.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 1.5 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.5 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 1.2 | GO:0046479 | glycolipid catabolic process(GO:0019377) glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) |
0.2 | 0.5 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.2 | 0.2 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 1.0 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.2 | 1.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 3.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 2.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 1.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.7 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.7 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 0.9 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 1.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 2.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.9 | GO:1903756 | regulation of postsynaptic density protein 95 clustering(GO:1902897) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 1.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 1.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.7 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 1.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.9 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.2 | 0.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 3.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 3.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 1.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 2.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 1.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 6.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 1.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 0.4 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 2.7 | GO:0032527 | retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
0.2 | 0.2 | GO:0098792 | xenophagy(GO:0098792) regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.8 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.2 | 1.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.2 | 1.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 1.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 1.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 2.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 1.6 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 1.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.8 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 6.6 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 1.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 2.5 | GO:0042119 | neutrophil activation(GO:0042119) |
0.2 | 0.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.2 | 0.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 1.1 | GO:0048521 | negative regulation of behavior(GO:0048521) |
0.2 | 2.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 0.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.6 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 0.6 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.2 | 1.8 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 2.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 2.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 1.1 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.2 | 1.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 9.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 2.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 3.7 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.7 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 5.1 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.2 | 2.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 1.9 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.2 | 1.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 2.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 1.2 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.2 | 1.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 3.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 0.7 | GO:0006901 | vesicle coating(GO:0006901) |
0.2 | 1.0 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.2 | 0.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.9 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 2.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 3.7 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.8 | GO:0048793 | pronephros development(GO:0048793) |
0.2 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 1.2 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 0.7 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.2 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 3.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 1.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.3 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.2 | 2.0 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.2 | 1.6 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.2 | 1.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 2.4 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 2.2 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.2 | 0.5 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.2 | 4.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 1.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 3.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 2.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 4.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.9 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.2 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 0.8 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 2.7 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.6 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 11.1 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 1.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 1.0 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 6.2 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 3.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 1.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.6 | GO:2000480 | regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.9 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.0 | GO:0090234 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.1 | 3.9 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 2.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 1.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.3 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 4.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 2.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 1.5 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 0.1 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 1.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 4.2 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 2.5 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 9.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 1.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 2.6 | GO:0086001 | cardiac muscle cell action potential(GO:0086001) |
0.1 | 1.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.4 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 6.1 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 1.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.6 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 4.8 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.5 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.1 | 3.4 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 1.0 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 2.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 1.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 2.8 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.1 | 4.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 1.6 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:0046888 | negative regulation of hormone secretion(GO:0046888) |
0.1 | 0.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.6 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.1 | 0.9 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 1.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 7.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 2.0 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
0.1 | 4.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.7 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 1.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 3.0 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.9 | GO:0045851 | pH reduction(GO:0045851) intracellular pH reduction(GO:0051452) |
0.1 | 1.9 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.7 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.7 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 4.1 | GO:0071222 | cellular response to molecule of bacterial origin(GO:0071219) cellular response to lipopolysaccharide(GO:0071222) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 6.7 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 1.3 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.1 | 0.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 1.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 3.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 4.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 1.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 1.4 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 2.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 1.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.1 | 1.3 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 1.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.3 | GO:0032472 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) manganese ion homeostasis(GO:0055071) |
0.1 | 3.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 1.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 6.1 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.1 | 2.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 1.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 3.1 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 0.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 1.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.9 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.6 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 5.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 9.6 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.4 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.1 | 1.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 1.3 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.4 | GO:0042092 | type 2 immune response(GO:0042092) |
0.1 | 1.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 1.2 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 1.0 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 0.9 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.0 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.3 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.6 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 1.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.4 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 1.3 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 1.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.4 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 1.5 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.0 | 1.2 | GO:0034614 | cellular response to reactive oxygen species(GO:0034614) |
0.0 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 2.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.7 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.6 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.0 | 0.5 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0015809 | arginine transport(GO:0015809) |
0.0 | 1.6 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0051295 | polar body extrusion after meiotic divisions(GO:0040038) establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.2 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.2 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.0 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.0 | 0.0 | GO:1903115 | regulation of cardiac muscle cell contraction(GO:0086004) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.8 | GO:0050817 | coagulation(GO:0050817) |
0.0 | 0.1 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) negative regulation of sequestering of calcium ion(GO:0051283) |
0.0 | 2.1 | GO:0060271 | cilium morphogenesis(GO:0060271) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 57.7 | GO:0005614 | interstitial matrix(GO:0005614) |
3.4 | 10.3 | GO:0072534 | perineuronal net(GO:0072534) |
3.1 | 9.3 | GO:0098830 | presynaptic endosome(GO:0098830) |
2.5 | 10.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
2.4 | 7.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.3 | 13.9 | GO:0097443 | sorting endosome(GO:0097443) |
2.1 | 8.5 | GO:0097441 | basilar dendrite(GO:0097441) |
2.1 | 8.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.7 | 5.1 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
1.7 | 10.1 | GO:0045179 | apical cortex(GO:0045179) |
1.7 | 8.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.7 | 6.6 | GO:0060076 | excitatory synapse(GO:0060076) |
1.7 | 23.1 | GO:0016342 | catenin complex(GO:0016342) |
1.5 | 44.5 | GO:0033268 | node of Ranvier(GO:0033268) |
1.5 | 13.1 | GO:0042587 | glycogen granule(GO:0042587) |
1.4 | 4.3 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
1.4 | 5.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.4 | 12.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.3 | 30.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.3 | 7.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
1.3 | 45.6 | GO:0090544 | BAF-type complex(GO:0090544) |
1.2 | 3.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.2 | 10.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.2 | 12.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.1 | 6.6 | GO:0071439 | clathrin complex(GO:0071439) |
1.1 | 1.1 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
1.0 | 8.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.0 | 4.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.0 | 2.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.0 | 9.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.9 | 4.7 | GO:1990037 | Lewy body core(GO:1990037) |
0.9 | 4.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.9 | 2.7 | GO:0098855 | HCN channel complex(GO:0098855) |
0.9 | 0.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.9 | 6.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 4.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.9 | 6.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 16.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 3.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.8 | 3.0 | GO:0097447 | dendritic tree(GO:0097447) |
0.7 | 3.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.7 | 2.2 | GO:0034657 | GID complex(GO:0034657) |
0.7 | 5.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.7 | 5.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 4.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.7 | 9.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.7 | 2.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.7 | 2.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.7 | 2.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.7 | 9.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 3.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 2.6 | GO:0044308 | axonal spine(GO:0044308) |
0.7 | 8.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.6 | 4.5 | GO:0005638 | lamin filament(GO:0005638) |
0.6 | 2.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.6 | 12.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.6 | 15.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.6 | 7.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.6 | 1.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.6 | 17.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 1.7 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.5 | 1.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 3.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.5 | 5.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 1.5 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.5 | 10.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 1.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 7.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 2.9 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.5 | 7.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.5 | 6.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 2.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 2.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 5.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 1.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 8.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.4 | 3.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 1.3 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 2.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 1.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 6.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 0.8 | GO:0030670 | endocytic vesicle membrane(GO:0030666) phagocytic vesicle membrane(GO:0030670) |
0.4 | 1.1 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.4 | 3.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.4 | 1.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 8.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 1.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.3 | 2.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.3 | 8.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.3 | 9.4 | GO:0031430 | M band(GO:0031430) |
0.3 | 1.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 5.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 3.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 2.6 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 2.3 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 4.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 1.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.3 | 4.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 9.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 11.7 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 40.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 1.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 14.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 4.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 2.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
0.3 | 7.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 1.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 4.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 8.3 | GO:0030118 | clathrin coat(GO:0030118) |
0.3 | 1.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 0.8 | GO:0014802 | terminal cisterna(GO:0014802) |
0.3 | 5.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 2.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 1.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 3.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 0.8 | GO:0097386 | glial cell projection(GO:0097386) |
0.3 | 0.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.3 | 2.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 5.0 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 4.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 12.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 2.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 2.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 2.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 46.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 9.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 40.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 4.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 4.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 6.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 1.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 1.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 31.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 1.2 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 2.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 5.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 16.0 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 1.9 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 6.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 3.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 5.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.8 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 10.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 3.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 1.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 2.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 4.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 12.9 | GO:0005814 | centriole(GO:0005814) |
0.2 | 1.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 10.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 3.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 12.8 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 2.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 4.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 3.0 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 18.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 2.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 3.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 3.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 1.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 4.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 4.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 2.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 9.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 5.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 10.6 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.1 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 8.7 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 2.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 2.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 221.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 1.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 1.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 2.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 2.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 2.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 2.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 2.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 1.5 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 2.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 27.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
4.3 | 12.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
3.4 | 10.1 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
2.7 | 10.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
2.7 | 10.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
2.2 | 8.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
2.1 | 8.4 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
2.1 | 6.2 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
2.0 | 10.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
2.0 | 8.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
2.0 | 11.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.9 | 13.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
1.8 | 5.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.7 | 5.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
1.7 | 6.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.6 | 14.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.6 | 4.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.6 | 4.7 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
1.5 | 10.7 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.5 | 4.5 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
1.5 | 6.0 | GO:0038025 | reelin receptor activity(GO:0038025) |
1.5 | 10.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.5 | 4.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.4 | 4.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.4 | 5.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.4 | 4.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.3 | 5.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.3 | 15.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.3 | 3.9 | GO:0008527 | taste receptor activity(GO:0008527) |
1.3 | 7.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.3 | 3.8 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
1.3 | 13.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.2 | 3.7 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
1.2 | 4.9 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
1.2 | 4.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.2 | 12.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.2 | 8.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.2 | 3.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
1.2 | 11.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.1 | 10.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.1 | 7.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.1 | 6.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.1 | 6.3 | GO:0045545 | syndecan binding(GO:0045545) |
1.0 | 23.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.0 | 10.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.0 | 3.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.0 | 3.9 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
1.0 | 2.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.0 | 32.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.9 | 4.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.9 | 23.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.9 | 2.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.9 | 6.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 8.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.9 | 19.1 | GO:0071949 | FAD binding(GO:0071949) |
0.9 | 4.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.8 | 3.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.8 | 5.0 | GO:0070728 | leucine binding(GO:0070728) |
0.8 | 5.9 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.8 | 29.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.8 | 3.3 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.8 | 2.5 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.8 | 4.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.8 | 4.9 | GO:0089720 | caspase binding(GO:0089720) |
0.8 | 6.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 3.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.8 | 5.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 4.6 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.8 | 12.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 3.0 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.7 | 5.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 2.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 0.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 0.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.7 | 2.9 | GO:0034481 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) chondroitin sulfotransferase activity(GO:0034481) |
0.7 | 4.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 6.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.7 | 2.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.7 | 3.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.7 | 2.7 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.7 | 10.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 18.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.7 | 2.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 3.3 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.7 | 2.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.7 | 2.0 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.6 | 7.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.6 | 11.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.6 | 5.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.6 | 3.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 2.4 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.6 | 13.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.6 | 1.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.6 | 2.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 8.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.6 | 2.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.6 | 1.7 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.6 | 8.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.6 | 1.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.6 | 12.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 1.6 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.5 | 1.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 7.4 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 1.6 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.5 | 6.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 6.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.5 | 2.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 3.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 5.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 3.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 1.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 5.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 4.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 15.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 11.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 1.5 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.5 | 29.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.5 | 1.5 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.5 | 6.9 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 12.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 9.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.5 | 2.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 26.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.5 | 8.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.5 | 2.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 4.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 4.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 2.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 2.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 24.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 2.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 1.7 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 1.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.4 | 1.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 0.4 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.4 | 1.3 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.4 | 5.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 0.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 0.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 2.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.4 | 8.0 | GO:0031402 | sodium ion binding(GO:0031402) |
0.4 | 2.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 8.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 5.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 0.8 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.4 | 4.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 8.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 3.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 1.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 8.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 4.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 3.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.4 | 12.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 1.1 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.4 | 11.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 3.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 1.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 2.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 6.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 2.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 1.7 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.3 | 12.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 1.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 3.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 1.0 | GO:0045127 | N-acylmannosamine kinase activity(GO:0009384) N-acetylglucosamine kinase activity(GO:0045127) |
0.3 | 1.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 2.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 1.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 2.9 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 2.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 52.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 4.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 3.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 0.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 3.0 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 0.9 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.3 | 1.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 1.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 1.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 3.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 6.1 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.3 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.3 | 2.6 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.3 | 11.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 2.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 1.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 0.8 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 0.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 4.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 54.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.3 | 1.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 2.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 26.8 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 3.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 0.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 2.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.3 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 2.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 1.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 1.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 2.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.2 | 5.4 | GO:0042287 | MHC protein binding(GO:0042287) |
0.2 | 1.0 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 1.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 1.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 5.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 1.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.7 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 5.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 2.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 2.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 19.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 11.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 8.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.7 | GO:0004980 | melanocortin receptor activity(GO:0004977) melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 14.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 1.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 0.6 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.2 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 3.6 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 1.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 3.1 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 7.1 | GO:0016247 | channel regulator activity(GO:0016247) |
0.2 | 1.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 2.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 6.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 1.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 4.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 3.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 6.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.2 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.2 | 2.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 2.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 10.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.2 | 3.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 2.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.8 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.2 | 3.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 3.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 2.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.2 | 1.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 5.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 3.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 1.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 11.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 4.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 4.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 7.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 4.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.4 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.1 | 1.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 9.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 3.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 3.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.6 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 1.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 3.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 8.5 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 1.8 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.2 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 1.2 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 3.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 2.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.3 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 2.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 2.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 2.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 1.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 4.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 2.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 5.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 2.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 13.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.5 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.1 | 33.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.7 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 1.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 20.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.8 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.1 | 3.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.7 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 1.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 4.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 1.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 1.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 3.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 2.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 1.1 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.0 | 1.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.4 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 4.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 2.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.0 | GO:0070513 | death domain binding(GO:0070513) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 7.6 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.6 | 33.6 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
0.6 | 32.8 | PID_REELIN_PATHWAY | Reelin signaling pathway |
0.6 | 43.0 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
0.6 | 16.4 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.6 | 13.2 | PID_IL1_PATHWAY | IL1-mediated signaling events |
0.5 | 16.0 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
0.5 | 23.2 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
0.4 | 12.5 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 12.4 | PID_ARF_3PATHWAY | Arf1 pathway |
0.4 | 11.0 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 4.4 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.3 | 37.6 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 3.6 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 7.3 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 3.1 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 2.4 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
0.3 | 7.5 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 7.1 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 8.5 | PID_BCR_5PATHWAY | BCR signaling pathway |
0.2 | 2.3 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 8.1 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
0.2 | 3.1 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
0.2 | 5.0 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 21.4 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
0.2 | 4.9 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
0.2 | 2.6 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.2 | 2.6 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
0.2 | 4.5 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 2.5 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
0.2 | 11.3 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.0 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 3.3 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
0.1 | 3.5 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.4 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.0 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
0.1 | 4.6 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.7 | PID_IFNG_PATHWAY | IFN-gamma pathway |
0.1 | 3.5 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
0.1 | 5.4 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.1 | 3.9 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.8 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.8 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.6 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.7 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.4 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.2 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
0.1 | 0.5 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.8 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.6 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 12.8 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.1 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.6 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
0.1 | 2.3 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
0.1 | 2.2 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.1 | PID_ATM_PATHWAY | ATM pathway |
0.0 | 0.9 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
0.0 | 0.5 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
0.0 | 0.4 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
0.0 | 0.3 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID_RHODOPSIN_PATHWAY | Visual signal transduction: Rods |
0.0 | 0.7 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.2 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.0 | 0.4 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID_EPO_PATHWAY | EPO signaling pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 38.0 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.0 | 15.4 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.9 | 30.8 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.8 | 7.1 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.8 | 6.8 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 12.6 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.7 | 26.2 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
0.7 | 24.7 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 8.9 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 18.0 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 9.0 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.6 | 7.7 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 5.1 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.6 | 15.0 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
0.6 | 3.7 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 6.5 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 11.2 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 9.4 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
0.6 | 12.0 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.6 | 1.7 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.5 | 16.7 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.5 | 11.8 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
0.5 | 20.2 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 20.1 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 4.0 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 2.0 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 1.9 | REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.5 | 11.1 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 38.7 | REACTOME_L1CAM_INTERACTIONS | Genes involved in L1CAM interactions |
0.4 | 5.7 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 9.8 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.4 | 3.8 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 9.1 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 10.6 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.4 | 2.7 | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 14.5 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 1.5 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 4.9 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.4 | 4.8 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 6.2 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 4.2 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 3.1 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 2.4 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.3 | 4.3 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 9.9 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 12.4 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.3 | 6.5 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 13.1 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 11.9 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 0.6 | REACTOME_SHC_RELATED_EVENTS | Genes involved in SHC-related events |
0.3 | 2.6 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 2.9 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 6.4 | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.3 | 10.1 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 2.4 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 1.3 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 12.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 4.9 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 16.8 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 7.2 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 1.4 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.6 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 4.1 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 2.9 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 1.6 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
0.2 | 3.1 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.7 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 0.6 | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 5.0 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
0.2 | 2.3 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 1.7 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 3.2 | REACTOME_ZINC_TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 3.9 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 3.1 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 2.7 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 0.5 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 4.8 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 2.8 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 3.8 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 0.7 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 2.2 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 5.4 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 0.8 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.2 | 0.5 | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.2 | 1.2 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 0.9 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
0.1 | 5.2 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.0 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.6 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 2.1 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
0.1 | 3.3 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.1 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.9 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.2 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.7 | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 4.8 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.7 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.9 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.8 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.3 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.6 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 8.4 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.6 | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.9 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.7 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.6 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.6 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.8 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.2 | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.4 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.9 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.0 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.8 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.6 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 2.6 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.7 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.8 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.5 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.6 | REACTOME_DOUBLE_STRAND_BREAK_REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 2.9 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.6 | REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.7 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.3 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.9 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.1 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.2 | REACTOME_KINESINS | Genes involved in Kinesins |
0.0 | 2.0 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 3.8 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 2.3 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 2.3 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.4 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 2.3 | REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.9 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 1.5 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 2.1 | REACTOME_MEIOSIS | Genes involved in Meiosis |
0.0 | 0.2 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.4 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |